Tbr1-related Neurocognitive Disorder

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-11-21
Clinical Trial Update: A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With TBR1-related Neurocognitive Disorder [Phase 1, Phase 2]
This entry describes a pilot, multicentre, open-label Phase 1/2 trial evaluating 24 months of lithium carbonate in patients with TBR1-relate…